This inventor holds 5 USPTO granted patents. Top assignees: University of Illinois, Other. Active years: 2008-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hillsborough, NJ (US) (2015 - 2018)
- Chicago, IL (US) (2008 - 2021)
Company Filing History:
3 out of 2,430 
2 out of 834,513 Years Active: 2008-2021
Title: The Innovative Contributions of Inventor Yonghua Zhu
Introduction
Yonghua Zhu is a prominent inventor based in Chicago, IL, known for his significant contributions in the field of biomedical research. With a notable portfolio of five patents, Zhu has worked to advance the understanding of ephrin signaling and its implications for treating cancer. His inventions reflect a commitment to harnessing scientific knowledge to develop novel therapeutic strategies.
Latest Patents
Yonghua Zhu's recent patents focus on "Compositions and methods for treating conditions related to ephrin signaling with cupredoxins." These patents detail innovative compositions and methodologies utilizing cupredoxins—such as azurin, rusticyanin, and plastocyanin—to disrupt the ephrin signaling system in mammalian cells. Notably, his invention aims to develop treatments for cancer in mammals, emphasizing the utility of cupredoxins and their derivatives. Furthermore, Zhu has explored the efficacy of mutants with altered Eph binding constants and selectivities, enhancing the potential applications of his research.
Career Highlights
Throughout his career, Yonghua Zhu has collaborated with esteemed institutions, including the University of Illinois. His role in these organizations has allowed him to further his research and innovation, contributing significantly to the scientific community. His work consistently showcases a blend of creativity and scientific rigor, establishing him as a key figure in his field.
Collaborations
Yonghua Zhu has partnered with notable colleagues such as Ananda M Chakrabarty and Tapas Das Gupta. These collaborations have fostered a dynamic approach to research, leading to significant advancements in understanding complex biological processes and potential treatments.
Conclusion
In conclusion, inventor Yonghua Zhu is a trailblazer whose work on treating conditions related to ephrin signaling has the potential to make a remarkable impact on cancer therapies. With a clear focus on innovation and scientific collaboration, his contributions continue to inspire advancements in biomedical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile